Valence8 Us LP Applied Therapeutics Inc. Transaction History
Valence8 Us LP
- $213 Billion
- Q1 2025
A detailed history of Valence8 Us LP transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Valence8 Us LP holds 20,300 shares of APLT stock, worth $7,308. This represents 0.07% of its overall portfolio holdings.
Number of Shares
20,300Holding current value
$7,308% of portfolio
0.07%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding APLT
# of Institutions
94Shares Held
103MCall Options Held
176KPut Options Held
165K-
Vestal Point Capital, LP New York, NY11.5MShares$4.14 Million0.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA11.3MShares$4.06 Million6.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.4MShares$3.74 Million0.0% of portfolio
-
Knoll Capital Management, LLC Miami, FL7.8MShares$2.81 Million2.55% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$2.37 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $17.3M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...